Moderna begins testing its vaccine on Kids. The COVID-19 vaccine has been put to the test in young children by Moderna.
Moderna begins testing its vaccine on kids. on Tuesday, March 16, the pharmaceutical company revealed that the first patients in a trial of children aged 6 months to 12 years old had received doses of its COVID-19 vaccine. The work was conducted in cooperation with Moderna, the National Institutes of Health, and the Biomedical Applied Research and Development Authority.
Moderna plans to enroll 6,750 people in the KidCOVE study, which will take place in the United States and Canada. The efficacy of the two-dose vaccine, given 28 days apart, will be tested by experts.
In the United States, a COVID-19 vaccine for people under the age of 16 has not been authorised. Owing to the rarity of severe COVID-19 illness in children, researchers based their initial vaccine experiments on adults.
Drug trials in children differ from those of adults, according to Cleveland Clinic, and there are more levels of security – all parents and children must choose to participate. Immune systems often differ based on a child’s age, resulting in more complicated trials compared to adult tests.
In a press release, Moderna CEO Stphane Bancel said, “We are inspired by the primary review of the Phase 3 COVE trial of mRNA-1273 in adults ages 18 and above, and this pediatric study will help us determine the possible safety and immunogenicity of our COVID-19 vaccine candidate in this significant younger age group.”